Publication:
Analysis of survival and prognostic factors in metastatic colorectal cancer patients treated with first line bevacizumab.

Simple item page
dc.contributor.authorsDemircan, Nazim; Dane, Faysal; Ozturk, Mehmet Akif; Besiroglu, Mehmet; Babacan, Nalan; Kaya, Serap; Ercelep, Ozlem; Simsek, Eda Tanrikulu; Halil, Suleyman; Koca, Sinan; Alan, Ozkan; Hasanov, Rahib; Yumuk, Perran Fulden
dc.date.accessioned2022-03-12T16:23:38Z
dc.date.accessioned2026-01-10T20:50:48Z
dc.date.available2022-03-12T16:23:38Z
dc.date.issued2017
dc.identifier.doi10.1200/JCO.2017.35.15_suppl.e15009
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/225943
dc.identifier.wosWOS:000411895707122
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleAnalysis of survival and prognostic factors in metastatic colorectal cancer patients treated with first line bevacizumab.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume35

Files

Collections

Araştırma Çıktıları